11:15am ET
Health and Healthcare
Jefferies Identifies 5 Top Biotech Stocks for Huge Upside
Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.
Companies
/Healthcare
Vertex Pharmaceuticals Inc
$541.69
▼ $5.86 (−1.07%) today
Markets closed · 10:16am ET
VRTX Coverage
Page 108:55am ET
Investing
Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and Many More
Monday's top analyst calls include Chipotle Mexican Grill, Cisco Systems, Micron Technology, Seagate Technology, VertexPharmaceuticals, Walt Disney and Xerox.
10:20am ET
Health and Healthcare
3 Key FDA Decisions Expected in February
24/7 Wall St. has collected three big FDA decisions coming up in February and added some color, along with the trading range and price target.
11:45am ET
Health and Healthcare
Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs
Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks with an Outperform rating.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More
Friday’s top analyst upgrades, downgrades and initiations include AIG, Facebook, Gilead Sciences, Google, Regeneron Pharmaceuticals, Twitter, Valeant Pharmaceuticals and Vertex Pharmaceuticals.
12:10pm ET
Health and Healthcare
Why Argus Thinks Now Is the Time to Buy Vertex
Argus has been waiting for a better valuation to upgrade Vertex Pharmaceuticals, and the recent weakness in the stock price has given the firm the opportunity.
Chris Lange 8:35am ET
Investing
Top Analyst Upgrades and Downgrades: Atmel, BlackBerry, Citigroup, DSW, JC Penney, 2U, TD Ameritrade, Vertex and Many More
Monday's top analyst upgrades, downgrades and initiations include Atmel, BlackBerry, Citigroup, DSW, JC Penney, 2U, TD Ameritrade and Vertex Pharmaceuticals.
8:35am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, DuPont, Frontier Communications, HP, HSBC, 3M, Red Hat and Many More
Tuesday's top analyst upgrades, downgrades and initiations include Apple, DuPont, Frontier Communications, Hewlett-Packard, HSBC, 3M and Red Hat.
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: AeroVironment, Gold Fields, Marvell, Nokia, Silver Wheaton and Many More
Monday's top analyst upgrades, downgrades and initiations include AeroVironment, Gold Fields, Marvell Technology, Nokia and Silver Wheaton.
8:35am ET
Health and Healthcare
3 Potential Huge Takeover Targets in Biotech
In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech companies could be targeted for buyouts.
9:15am ET
Investing
Large Companies With Fastest Revenue and Earnings Growth in 2015
S&P Capital IQ released a report regarding the performance of companies in terms of earnings and revenue.
8:30am ET
Health and Healthcare
Why These 4 Biotech Stocks Could Be the Next Buyout Targets
A new research note from SunTrust Robinson Humphrey mentions four stocks that they think could possibly get swept up in the biotech M&A excitement.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Citrix, Kythera, Mylan, Netflix, Weatherford and More
Friday's top analyst upgrades, downgrades and initiations include Apple, Citrix Systems, Kythera Biopharmaceuticals, Mylan, Netflix and Weatherford International.
8:35am ET
Health and Healthcare
RBC Has 4 Biotech Stocks to Buy After Massive Pullback
In a new report from RBC, while they think the selling and profit taking in biotechs could go on, they also hold fast that industry fundamentals are still very positive.
8:45am ET
Health and Healthcare
Why Deutsche Bank Says to Buy Gilead and Vertex Pullbacks
Deutsche Bank says that investors have misread the current instances floating around two leading biotech stocks, and they both should be bought now on any continuing weakness.